250 related articles for article (PubMed ID: 1828394)
1. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.
Chittenden T; Livingston DM; Kaelin WG
Cell; 1991 Jun; 65(6):1073-82. PubMed ID: 1828394
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
3. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
Ouellette MM; Chen J; Wright WE; Shay JW
Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
[TBL] [Abstract][Full Text] [Related]
4. The E2F transcription factor is a cellular target for the RB protein.
Chellappan SP; Hiebert S; Mudryj M; Horowitz JM; Nevins JR
Cell; 1991 Jun; 65(6):1053-61. PubMed ID: 1828392
[TBL] [Abstract][Full Text] [Related]
5. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.
Bagchi S; Weinmann R; Raychaudhuri P
Cell; 1991 Jun; 65(6):1063-72. PubMed ID: 1828393
[TBL] [Abstract][Full Text] [Related]
6. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
Ikeda MA; Nevins JR
Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
Wu EW; Clemens KE; Heck DV; Münger K
J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
[TBL] [Abstract][Full Text] [Related]
9. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
Nevins JR
Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535
[TBL] [Abstract][Full Text] [Related]
10. RB associates with an E2F-like, sequence-specific DNA-binding protein.
Chittenden T; Livingston DM; Kaelin WG
Cold Spring Harb Symp Quant Biol; 1991; 56():187-95. PubMed ID: 1819485
[No Abstract] [Full Text] [Related]
11. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
Bandara LR; La Thangue NB
Nature; 1991 Jun; 351(6326):494-7. PubMed ID: 1710781
[TBL] [Abstract][Full Text] [Related]
12. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
13. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert SW; Chellappan SP; Horowitz JM; Nevins JR
Genes Dev; 1992 Feb; 6(2):177-85. PubMed ID: 1531329
[TBL] [Abstract][Full Text] [Related]
14. E2F transcription factor is a target for the RB protein and the cyclin A protein.
Nevins JR; Chellappan SP; Mudryj M; Hiebert S; Devoto S; Horowitz J; Hunter T; Pines J
Cold Spring Harb Symp Quant Biol; 1991; 56():157-62. PubMed ID: 1840249
[No Abstract] [Full Text] [Related]
15. Transcription factor E2F binds DNA as a heterodimer.
Huber HE; Edwards G; Goodhart PJ; Patrick DR; Huang PS; Ivey-Hoyle M; Barnett SF; Oliff A; Heimbrook DC
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3525-9. PubMed ID: 8475102
[TBL] [Abstract][Full Text] [Related]
16. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
17. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
[TBL] [Abstract][Full Text] [Related]
18. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Sellers WR; Rodgers JW; Kaelin WG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
[TBL] [Abstract][Full Text] [Related]
19. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Flemington EK; Speck SH; Kaelin WG
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
[TBL] [Abstract][Full Text] [Related]
20. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
